Impairment of Immunological Functions in Genetically Epilepsy-Prone Rats

By De Sarro G.   Liberto M.C.   Berlinghieri M.C.   Foca A.   Aragona M.   Cavaliere R.   Gulletta E.  

General Pharmacology, Vol. 27, Iss. 4, 1996-06 ,pp. : 643-646

Elsevier

Access to resources Recommend Favorite

Effect of norepinephrine release on adrenoceptors in severe seizure genetically epilepsy-prone rats

By Seo D.O.   Shin C.Y.   Ryu J.R.   Cheong J.H.   Choi C.-R.   Dailey J.W.   Reith M.E.A.   Jobe P.C.   Ko K.H.  

European Journal of Pharmacology, Vol. 396, Iss. 2, 2000-05 ,pp. : 53-58

Elsevier

Access to resources Recommend Favorite

Neither intranigral fluoxetine nor 5,7-dihydroxytryptamine alter audiogenic seizures in genetically epilepsy-prone rats

By Statnick M.   Dailey J.   Jobe P.   Browning R.  

European Journal of Pharmacology, Vol. 299, Iss. 1, 1996-03 ,pp. : 93-102

Elsevier

Access to resources Recommend Favorite

Prolonged anticonvulsant action of glutamate metabotropic receptor agonists in inferior colliculus of genetically epilepsy-prone rats

By Tang E.   Yip P.K.   Chapman A.G.   Jane D.E.   Meldrum B.S.  

European Journal of Pharmacology, Vol. 327, Iss. 2, 1997-05 ,pp. : 109-115

Elsevier

Access to resources Recommend Favorite

Ocular pharmacokinetics/pharmacodynamics

By Worakul N.   Robinson J.R.  

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 44, Iss. 1, 1997-07 ,pp. : 71-83

Elsevier

Access to resources Recommend Favorite